Researchers at the University of Maryland School of Medicine have identified a peptide, or protein, derived from Pacific cod that may inhibit prostate cancer and possibly other cancers from spreading, according to preclinical research published online in the Proceedings of the National Academy of Sciences (PNAS)...
Colorectal Cancer Highlighted In The March GIE: Gastrointestinal Endoscopy
3/22/2013
In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer. The issue includes a practical guide for approaching and managing serrated colon polyps, one of the most common types of polyps, and a study on reducing postpolypectomy bleeding with prophylactic clip closure...
Vitamin D Supplements May Offer Immune Benefits, Even In Healthy Individuals
3/22/2013
Research from Boston University School of Medicine (BUSM) shows that improving vitamin D status by increasing its level in the blood could have a number of non-skeletal health benefits...
Cell Therapy Shows Promise For Advanced Leukemia In Adults
3/21/2013
An experimental therapy that alters cancer patients' own immune cells to identify a dangerous type of leukemia has also reduced tumors and sent the cancer into remission in adults, according to a new study published in Science Translational Medicine...
UCLA Researchers Monitor T Cell Function To Improve Melanoma Treatment
3/21/2013
UCLA and California Institute of Technology scientists from the UCLA Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research (Broad Stem Cell Research Center [BSCRC]) and the Jonsson Comprehensive Cancer Center (JCCC) led by James Heath, member of both centers, professor of molecular & medical pharmacology at UCLA and professor of chemistry at Caltech, have...
Beneficial effect of genetically engineered antitumor T cells was transient. Functionality of T cells changed over time. Strategies are needed to sustain antitumor functionality. Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time...
Virus-Based Melanoma Drug Shows Promise In Trial
3/21/2013
For the first time in a late stage trial, a virus-based cancer drug is showing some promising early results. The news that Amgen's melanoma drug talimogene laherparepvec (TVEC) has met the primary goal of a Phase 3 trial may revive interest in what has proved to be a rather elusive drug technology...
Research published in the journal Cancer Cell has revealed the mechanism by which leukaemia cells develop resistance to the ATRA (All-Trans-Retinoic Acid) treatment, used to treat an aggressive form of cancer called acute promyelocytic leukemia (APL: a fast-growing cancer in which there are too many immature blood-forming cells in the blood and bone marrow)...
Yogurt Organisms 'PERFECT' Specimen For Cancer Research
3/21/2013
Scientists at The Cancer Institute of New Jersey explore effects of probiotics on bone marrow transplant outcomes One may not think of probiotics - like those found in yogurt that promote good digestive health - as a weapon used in the fight against cancer...
Scientists Identify Gene Fault With A Domino Effect On Cancer Risk
3/21/2013
Scientists have identified a brand new genetic mechanism that raises the risk of cancer via a domino effect on DNA - with one gene fault triggering a second, cancer-causing mutation. A team at The Institute of Cancer Research, London, found some cancer patients inherit a weak point in their DNA that appears to leave one of their chromosomes vulnerable to snapping and becoming mutated...